shares – The Inside Adviser

June shakeup for most-traded ASX stocks; tech boom driving US gains

July 17, 2023 by Lisa Uhlman

After a three-month run as the most-traded ASX stock on Selfwealth’s platform, Neuron Pharmaceuticals ceded its spot to CBA in June as healthcare, mining and banking stocks jostled for investors’ attention.

Bringing performance into context after a shocking 2022

January 23, 2023 by Drew Meredith

Australia may have fared better than its international peers, but markets still took a pummelling in 2022 with traditional safe havens and equities alike bearing the brunt in a wildly dislocated market.

ASX edges ahead on Friday to cap listless week

April 25, 2021 by The Inside Adviser

Perth in lockdown, ASX flat for the week, retailers smashed Perth has entered a 'snap' three-day lockdown following another hotel quarantine outbreak. Despite this, the market finished slightly ahead on Friday,...

ASX rose to six-week high ahead of Easter break

April 4, 2021 by The Inside Adviser

Second quarter off to strong start, AMP's CEO departs, Boral announces buyback The ASX200 (ASX:XJO) finished the week and commenced the new quarter on a strong note, finishing 0.5% higher with both...

ASX records worst session in more than a month

March 30, 2021 by The Inside Adviser

Market down as Brisbane locks down, AGL to split, USD rallies The ASX200 (ASX:XJO) finished 0.9% lower after the Queensland Government announced a lockdown amid surging virus cases in Brisbane and surrounding...

ASX down but positive week

March 7, 2021 by The Inside Adviser

ASX down but positive week, energy shines, asset management dispersion The ASX200 (ASX:XJO) fell 0.7% on Friday but managed to deliver a positive return for the week, finishing 0.6% higher. The commodities...

ASX down as dividends rule the day

March 4, 2021 by The Inside Adviser

ASX down as dividends rule the day, retail sales recover but Myer (ASX:MYR) smashed The ASX200 (ASX:XJO) fell another 0.8% on Thursday, dragged down by a flurry of major companies paying out...

Tough finish to the week

February 21, 2021 by The Inside Adviser

Tough finish to the week, Cochlear (ASX:COH) rallies despite taking a hit, QBE Insurance (ASX:QBE) reports billion dollar loss The ASX200 (ASX:XJO) dropped 1.3% on Friday, sending the benchmark to a 0.2%...

Market falls flat, AMP offer pulled

February 11, 2021 by The Inside Adviser

Market falls flat, Telstra (ASX:TLS) affirms dividend, AMP (ASX:AMP) offer pulled The ASX200 (ASX:XJO) fell 0.1% on Thursday as reporting stepped up another level. The IT sector fell 2.1% giving up recent...

ASX rallies on the back of QE pump priming

February 2, 2021 by The Inside Adviser

ASX rallies on the back of QE pump priming, healthcare falls, Tabcorp (ASX:TAH) confirms bid The ASX200 (ASX:XJO) continued its strong start to the week, finishing 1.5% higher after news that the Reserve...

ASX struggles under COVID-19 weight

December 23, 2020 by Drew Meredith

ASX struggles under COVID-19 weight, banks fall, retail sales recover The ASX200 (ASX:XJO) struggled today, falling 1.1%, as concern around the NSW COVID-19 outbreak weighed on sentiment at the same time that volumes fall...

ASX finishes flat

December 21, 2020 by Drew Meredith

ASX finishes flat, border closures hit travel, AGL Energy downgrades, weaker open ahead The ASX200 (ASX:XJO) finished flat to begin the week, with news that US politicians finally agreed on a USD$900...

Winning streak hits seven weeks

December 20, 2020 by Drew Meredith

Winning streak hits seven weeks, A2 Milk (ASX:A2M) and Mesoblast (ASX:MSB) battered The ASX200 (ASX:XJO) managed to overcome a 1.2% fall to cap off the seventh straight week of gains, adding 0.5%....

DNR Capital: “Quality companies poised to win”

July 28, 2020 by Contributor

Market risks appear more balanced, quality companies poised to win market share.